PharmaRadar360

Entity and regulatory intelligence

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 602 of 745

Advanced search

🌍Jul 5Researchdoi.orgTier 1 · Research record

<scp>sFlt</scp> ‐1/ <scp>PlGF</scp> Ratio in the Diagnosis of Preeclampsia on the <scp>MAGLUMI X3</scp> Analyzer

CrossrefOriginal source

🌍Jul 5Researchdoi.orgTier 1 · Research record

Application of Cell‐Free <scp>DNA</scp> Barcode‐Enabled Single‐Molecule Test for Non‐Invasive Prenatal Testing of α‐Thalassemia and β‐Thalassemia

CrossrefOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Dong Nai Pharmaceutical Joint Stock Co – UPCOM:DPP

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Hanmi Pharmaceutical Co., Ltd. – KRX:128940

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Capricor Sinks After FDA Rejects Drug for Muscle Disease

MSNOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

UNCY stock clocks worst day in a year — analysts keep buy ratings despite ‘5-12 month delay’ in drug approval

MSNOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. – TSE:4534

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Nanjing Pharmaceutical Group Company Limited Class A – SSE:600713

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Nanjing Pharmaceutical Group Company Limited Class A – SSE:600713

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

US FDA rejects approval of Unicycive’s kidney disease therapy

MSNOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Apeloa Pharmaceutical Co. Ltd. Class A – SZSE:000739

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Apeloa Pharmaceutical Co. Ltd. Class A – SZSE:000739

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Mochida Pharmaceutical Co., Ltd. – LS:859288

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Guizhou Yibai Pharmaceutical Co. Ltd. Class A – SSE:600594

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Nanjing Pharmaceutical Group Company Limited Class A – SSE:600713

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

FDA approval for Travere's drug expands reach to broader rare kidney disease patients

MSNOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

The buntanetap program - Annovis Bio bets on neurodegeneration trials

AD HOC NEWSOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Number of shareholders of Nanjing Pharmaceutical Group Company Limited Class A – SSE:600713

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Nanjing Pharmaceutical Group Company Limited Class A – SSE:600713

TradingViewOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Everolimus Versus Elacestrant + Placebo in ER+/HER2- Advanced Breast Cancer (aBC) Patients With ESR1-Mutated Tumors Progressing on Endocrine Therapy

CancerNetworkOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Global Health Challenges: FDA Investigation, Ebola Trial, and Brazil's Antimicrobial Compliance

DevdiscourseOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Why The Apitegromab Clinical Trial Is Exciting News Connaught School For Girls Strike (C1BVuIvMaB)

MshaleOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

TuHURA Biosciences names Amanda Garofalo as clinical operations SVP

Investing.comOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

US researchers find widely used asthma drug impacts the brain

The Eastleigh VoiceOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

US probes Germany's 'persistent underpayment' for drugs

dw.comOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Yahoo FinanceOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Q1 2026 slides: ADHD growth drives earnings beat

Investing.comOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

First Half 2026 Recap - Endocrinology

HCPLiveOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

AJMCOriginal source

🌍Jul 5discoverynews.google.comTier 2 · Trade media

Between two giants: Europe’s new oncology chapter takes shape in Paris

Pharmaceutical TechnologyOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Maharashtra bans sale of high-caffeine energy drinks near schools

DaijiworldOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

5 Most Undervalued NASDAQ Stocks to Buy Right Now

Insider MonkeyOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Regeneron (REGN) Secures FDA Priority Review And EMA Acceptance For Cemdisiran

Yahoo Finance SingaporeOriginal source

🌍Jul 5discoverynews.google.comTier 3 · Aggregated media

Prosecutors seek answers amid cooking oil scandal

Taipei TimesOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Sellas Life Sciences: 78 Events Down, Two to Go — The Trial That Will Settle the Bulls vs. Bears S

AD HOC NEWSOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Ipsen acquires Memo Therapeutics for up to $800 million

qz.comOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Pune FDA Suspends Food Safety Licences of Seven Hotels, Restaurants.

Sprouts NewsOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Alibaba to Pay $600M Over Allegations of Illegal Pharmaceutical Sales in the U.S.

MedPage TodayOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

The US is hooked on unregulated peptides. But are they effective, or even safe?

Live ScienceOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Sihuan Pharmaceutical Holdings Group Ltd. – LSX:A1C72G

TradingViewOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?

The Motley FoolOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?

Yahoo FinanceOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics

AOL.comOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Health News Briefs: Anesthesia Concerns, Ebola Innovations, and Global Health Challenges

DevdiscourseOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

FDA is launching a pilot program to shorten early drug trials and counter China

qz.comOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Book value per share of Sunhawk Vision Biotech, Inc. – TPEX:7759

TradingViewOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Tango Therapeutics stock surges on pancreatic cancer trial data

qz.comOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%

AOL.comOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical manufacturer relocating corporate headquarters to Cincinnati

WKRCOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Know Your Company Episode 10 - Let's Talk About Boehringer Ingelheim Msci World Index (QJdK4sNal9)

MshaleOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Seven Pune Restaurants Lose Food Licences as FDA Cracks Down on Hygiene Violations

Pune MirrorOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Unicycive's drug to treat elevated phosphate levels in dialysis patients

MSNOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

302,995 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Purchased by Y Intercept Hong Kong Ltd

MarketBeatOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Maharashtra schools to get new food standards; FDA warns against 'energy drinks'

Careers360Original source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying

The Globe and MailOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhes Crackdown: FDA Suspends 7 Pune Food Establishments Over Hygiene Violations

Free Press JournalOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

J&J’s Imaavy shows positive results in wAIHA trial By Investing.com

Investing.com NigeriaOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Shows Strong Value Potential with a 7/10 Overall Rating

ChartMillOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A – SSE:603811

TradingViewOriginal source

🌍Jul 4discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings

Yahoo FinanceOriginal source